What we offer
With same day appointments our diagnostics service includes some of the latest technology including MRI, PET/CT, CT, Ultrasound, Mammography, digital X-ray and specialist clinics.
We’re always investing in the most advanced proven technologies and evidenced based treatments to deliver targeted radiotherapy treatments.
We offer state-of -the-art anti-cancer drugs delivered under the supervision of some of the best leading Oncologists.
Through our partnership with Penny Brohn UK we offer holistic treatments such as reflexology, acupuncture and relaxation as well as mindfulness meditation & counselling for all of our patients and their families.
Theranostics is a revolutionary, personalised approach to cancer medicine that brings together therapy and diagnostics. It enables us to combine a fast and accurate cancer diagnosis with precisely targeted therapy. It’s particularly effective for cancers that are difficult to treat or aren’t responding to conventional therapies.
Conditions we treat
We offer treatments for a wide range of cancers using the latest technology and most advanced techniques to design better care, providing personalised treatments to all our patients to deliver better outcomes and quality of life.
We offer low level radiotherapy to reduce the pain associated with degenerative or inflammatory conditions such as Dupuytren’s and Ledderhose disease as well as Plantar fasciitis and Achilles tendonitis.
Our oncology services in the UK
Search for a centre near you
Meet our doctors
We attract and retain some of the most experienced doctors in the country and have an unwavering focus on providing the highest quality patient care.
Our team of doctors specialise in certain areas of the body and conditions.
News and events
Read our latest news from across the globe. Learn about updates in technology, clinical advancements and new centre launches.
GenesisCare is highly active in clinical research. Our understanding of the treatments available to combat cancer today would not be possible without clinical research.
Who we are
We are 2,400 highly trained healthcare professionals and support staff across Australia, the U.K. and Spain designing innovative treatments and care for people with cancer and heart disease.